Fairvalue-Calculator Fairvalue-Calculator
EN DE

Invion Limited (IVIXF) Fair Value & Analysis

Healthcare · US · Market cap $4.0M

Price$0.0369
Fair Value$0.1500
Upside+306.5%
Quality95/100
Evidence: Low Range $0.1200 – $0.1900

Fair value as of: Jun 25, 2026

Analysis

Invion Limited (IVIXF) currently trades at $0.0369, while our model-based Fair Value estimate is $0.1500 — implying the stock looks roughly 306.5% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Invion Limited (IVIXF) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.1500 versus a price of $0.0369 — about +307% (undervalued). Model-based estimate, not financial advice.
What is the fair value of IVIXF?
Our 21-model fair value for Invion Limited is $0.1500 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.0369.
What is the quality score of IVIXF?
Invion Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.